Vol 55, No 2 (2024)
Clinical vignette
Published online: 2024-03-05
Multidrug rescue for pediatric refractory ITP complicated by intracranial bleeding
DOI: 10.5603/ahp.98334
Acta Haematol Pol 2024;55(2):126-128.
Abstract
Not available
Keywords: immune thrombocytopeniaantiplatelet antibodiesrefractorinessintracranial bleedinginfant
References
- Miltiadous O, Hou M, Bussel JB. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment. Blood. 2020; 135(7): 472–490.
- Neunert C, Heitink-Polle KMJ, Lambert MP. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group. Br J Haematol. 2023; 203(1): 17–22.
- Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019; 3(23): 3829–3866.
- Ibrahim L, Dong SX, O'Hearn K, et al. Pediatric refractory immune thrombocytopenia: A systematic review. Pediatr Blood Cancer. 2023; 70(3): e30173.
- Vianelli N, Auteri G, Buccisano F, et al. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives. Ann Hematol. 2022; 101(5): 963–978.
- Kjeldsen-Kragh J, Fergusson DA, Kjaer M, et al. Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome. Blood Adv. 2020; 4(14): 3368–3377.
- Zheng SS, Ahmadi Z, Leung HH, et al. Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia. Haematologica. 2022; 107(9): 2195–2205.
- Marini I, Zlamal J, Faul C, et al. Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan. Haematologica. 2021; 106(1): 196–207.
- Zheng SS, Perdomo JS, Leung HH, et al. Acquired Glanzmann thrombasthenia associated with platelet desialylation. J Thromb Haemost. 2020; 18(3): 714–721.
- Kochhar M, Neunert C. Immune thrombocytopenia: A review of upfront treatment strategies. Blood Rev. 2021; 49: 100822.